Printer-friendly versionSend to friend
Recognizing the looming therapeutic drug discovery pipeline problem, the Life Sciences Institute (LSI) Leadership Council, a visionary group of thought-leaders from science, pharma, public sector and finance created the Innovation Partnership.
The Innovation Partnership harnesses the power of philanthropic giving, world-class scientific expertise, and business best practices and focuses this power on one goal: moving our most promising scientific discoveries from scientists to patients.
How it works:
The Innovation Partnership at the U-M Life Sciences Institute infuses the projects of LSI scientists with funding from dedicated donors and expertise from leaders in the top ranks of business, venture capital, and the biomedical industry. Scientists at the LSI study human health at the molecular level, understanding and fighting disease where it starts.
Focusing on projects with the greatest potential for commercialization, a team of nationally renowned business executives and venture capitalists is formed to mentor scientists through the process from scientific discovery to the development into a drug.
The team works with scientists to create a plan to keep projects on the trajectory for success, which means an outcome that benefits patients and fights disease.
One of the first year’s projects was launched as a spin-off company focusing on the treatment of diabetes. The other three projects made stellar progress in the areas of neurodegenerative, bacterial infection, and cancer and have been funded for a second year.
For more information contact: Liz Barry, Managing Director.